PSMB9 and colon adenocarcinoma: On the whole, the results obtained in the present work provide a basis to investigate proteasome LMP2 subunit functions in mouse colon adenocarcinoma with the use of LMP2 inhibitor, and allow us to link the findings to proteasome mechanisms of gut cancer development in patients.